Search results
Stem cell transplant is commonly used to treat multiple myeloma. Before the transplant, drug treatment is used to reduce the number of myeloma cells in the patient’s body. (See Drug Therapy for Multiple Myeloma ).) Stem cell transplants (SCT) can be autologous or allogeneic.
Autologous transplants are the most common type for multiple myeloma. Your stem cells are harvested (collected) from your body and frozen. Your own stem cells are put back in your body after you have chemotherapy. Allogeneic transplants also can treat multiple myeloma.
Jun 11, 2021 · A stem cell transplant is a treatment option for some people with multiple myeloma. It can be effective at improving overall survival, but relapses can often occur after a period of time.
Jun 8, 2024 · Stem cell transplantation for multiple myeloma involves a few sequential phases, beginning with the collection of stem cells, pretransplant medication and radiation, intravenous infusion of the stem cells, and maintenance therapy.
The standard of care for fit multiple myeloma patients is to receive high-dose chemotherapy (HDT) with autologous stem cell rescue. This procedure is also known as autologous stem cell transplant (ASCT). Autologous stem cell transplant can provide a deep response with long-term remission.
Feb 18, 2021 · Autologous stem cell transplantation (auto-SCT) has been the standard of care in eligible newly diagnosed multiple myeloma (MM) patients. Outcomes of patients with MM have improved significantly due to the advent of several novel drugs.
Sep 7, 2022 · One viable treatment option for multiple myeloma patients is a stem cell transplant. Learn about the procedure, costs, risks, and recovery of a bone marrow transplant.
